Cargando…
Effectiveness of low-intensity atorvastatin 5 mg and ezetimibe 10 mg combination therapy compared with moderate-intensity atorvastatin 10 mg monotherapy: A randomized, double-blinded, multi-center, phase III study
BACKGROUND: We compared the efficacy and safety of low-intensity atorvastatin and ezetimibe combination therapy with moderate-intensity atorvastatin monotherapy in patients requiring cholesterol-lowering therapy. METHODS: At 19 centers in Korea, 290 patients were randomized to 4 groups: atorvastatin...
Autores principales: | Lee, Seung-Ah, Hong, Soon Jun, Sung, Jung-Hoon, Kim, Kyung-Soo, Kim, Seong Hwan, Cho, Jin Man, Chun, Sung Wan, Lee, Sang Rok, Kim, Chul Sik, Kim, Tae Nyun, Kim, Dae Hyeok, Park, Hwan-Cheol, Kim, Byung Jin, Kim, Hyun-Sook, Choi, Ji-Yong, Hong, Young Joon, Chung, Joong Wha, Yoon, Seong Bo, Lee, Sang-Hak, Lee, Cheol Whan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681377/ https://www.ncbi.nlm.nih.gov/pubmed/38013289 http://dx.doi.org/10.1097/MD.0000000000036122 |
Ejemplares similares
-
Effects of ezetimibe/simvastatin 10/10 mg versus Rosuvastatin 10 mg on carotid atherosclerotic plaque inflammation
por: Oh, Minyoung, et al.
Publicado: (2019) -
Comparison of Ezetimibe/Simvastatin 10/20 mg Versus Atorvastatin 20 mg in Achieving a Target Low Density Lipoprotein-Cholesterol Goal for Patients With Very High Risk
por: Cho, Yun-Kyeong, et al.
Publicado: (2011) -
Atorvastatin 10 mg plus ezetimibe versus titration to atorvastatin 40 mg: attainment of European and Canadian guideline lipid targets in high-risk subjects ≥65 years
por: Constance, Christian, et al.
Publicado: (2014) -
Pharmacokinetics of fixed-dose combination of rosuvastatin 20 mg and ezetimibe 10 mg compared to concurrent administration of individual tablets in healthy Korean subjects
por: Hwang, Inyoung, et al.
Publicado: (2018) -
The comparative efficacy of ezetimibe added to atorvastatin 10 mg versus uptitration to atorvastatin 40 mg in subgroups of patients aged 65 to 74 years or greater than or equal to 75 years
por: Ben-Yehuda, Ori, et al.
Publicado: (2011)